Scienture Holdings, Inc. (FRA:4E4)

Market Cap	13.81M -53.9%
Revenue (ttm)	556.89K +207.9%
Net Income	-17.52M
EPS	-1.36
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1870
Previous Close	0.2000
Day's Range	0.1870 - 0.1870
52-Week Range	0.1870 - 3.0800
Beta	n/a
RSI	35.94
Earnings Date	Mar 26, 2026

About Scienture Holdings

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potas...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Employees: 17
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4E4

Financial Performance

Financial numbers in USD